Generation Bio Co. (GBIO) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
GBIO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GBIO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -715.8% | -661.9% |
| 2023 | 100.0% | -2346.9% | -2144.5% |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export GBIO earnings history in CSV or JSON format
Free sign-in required to download data
Generation Bio Co. (GBIO) Earnings Overview
As of May 8, 2026, Generation Bio Co. (GBIO) reported trailing twelve-month net income of -$63M, reflecting -0.7% year-over-year growth. The company earned $-9.30 per diluted share over the past four quarters, with a net profit margin of -661.9%.
Looking at the long-term picture, GBIO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$36M in fiscal 2018.
Generation Bio Co. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ARWR (-$301M net income, -0.2% margin), RCKT (-$223M net income), RARE (-$609M net income, -85.4% margin), GBIO has room to improve margins relative to the peer group. Compare GBIO vs ARWR →
GBIO Earnings vs Peers
Earnings metrics vs comparable public companies
GBIO Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$132M | -4.0% | -$142M | $-19.76 | -661.9% | -715.8% |
| 2023 | -$127M | +7.3% | -$139M | $-19.63 | -2144.5% | -2346.9% |
| 2022 | -$137M | -14.7% | -$141M | $-23.51 | - | - |
| 2021 | -$119M | -48.0% | -$119M | $-21.17 | - | - |
| 2020 | -$81M | -33.5% | -$81M | $-29.54 | - | - |
| 2019 | -$60M | -68.5% | -$62M | $-13.10 | - | - |
| 2018 | -$36M | - | -$37M | $-18.20 | -99452.8% | -103594.4% |
See GBIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GBIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GBIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGBIO — Frequently Asked Questions
Quick answers to the most common questions about buying GBIO stock.
Is GBIO growing earnings?
GBIO EPS of $-9.30 reflects slowing growth at -0.7%, below the 5-year CAGR of N/A. TTM net income is $-63M. Expansion rate has moderated.
What are GBIO's profit margins?
Generation Bio Co. net margin is -661.9%, with operating margin at -715.8%. Below-average margins reflect competitive or cost pressures.
How consistent are GBIO's earnings?
GBIO earnings data spans 2018-2024. The current earnings trend is -0.7% YoY. Historical data enables comparison across business cycles.